HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 365 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $479 | -83.4% | 9,155 | -88.3% | 0.00% | -85.7% |
| Q4 2023 | $2,894 | -7.5% | 78,318 | -4.4% | 0.02% | -32.3% |
| Q3 2023 | $3,129 | +172.8% | 81,934 | +157.6% | 0.03% | +181.8% |
| Q2 2023 | $1,147 | -59.2% | 31,807 | -56.8% | 0.01% | -67.6% |
| Q1 2023 | $2,811 | -21.0% | 73,629 | +17.7% | 0.03% | -32.0% |
| Q4 2022 | $3,559 | -99.5% | 62,562 | +252.6% | 0.05% | +525.0% |
| Q3 2022 | $701,000 | -79.7% | 17,745 | -77.4% | 0.01% | -78.9% |
| Q2 2022 | $3,448,000 | +141.3% | 78,374 | +120.5% | 0.04% | +375.0% |
| Q4 2021 | $1,429,000 | +62.6% | 35,547 | +68.5% | 0.01% | -11.1% |
| Q1 2021 | $879,000 | +260.2% | 21,092 | +53.0% | 0.01% | -10.0% |
| Q4 2019 | $244,000 | -23.5% | 13,789 | -33.1% | 0.01% | -33.3% |
| Q3 2019 | $319,000 | – | 20,606 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |